Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $21.00 Million |
|---|---|
| Enterprise Value | $21.62 Million |
| Earnings per Share | $0 |
| Beta | 0 |
| Outstanding Shares | 197,504,349 |
| P/E Ratio | -20.88 |
|---|---|
| PEG | -0.09 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 77.65 |
| Enterprise Value to EBIT | -21.24 |
| Enterprise Value to Net Income | -22 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.02 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is dedicated to formulating a range of treatments for serious neurological ailments, particularly those stemming from traumatic brain injuries.